Last session

Evolent Health, Inc. (EVH) on Decifer Markets

Why it ranks here

  • It costs about 0 times its yearly sales; the middle of its industry is 1. Cheaper than 98 in 100 companies we measure, against their own industries.
  • It makes about 21 cents of gross profit a year on each dollar of assets, more than 35 in 100 companies we measure.
  • Its share count barely changed over the last year. On not spreading the company over more shares it stands ahead of 51 in 100 companies we measure.
  • Its assets shrank about 25% over the last year. On keeping expansion modest it stands ahead of 99 in 100 companies we measure.
  • Its share price rose about 26% over the past year, leaving out the latest month. Stronger than 61 in 100 companies we measure.
  • We could not measure 2 of the seven scores for this company: safety and use of capital. Each counts as 50, the middle, until we can.

The current read

The evidence on EVH lines up on the supportive side: a live market force supports this name through its theme connection. The independent signals we track are telling the same story.

Read the full EVH research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.

Decifer Markets is a media publication. Nothing here is investment advice, a recommendation, or an offer to buy or sell any security.

DisclaimerTermsPrivacyAbout

Evolent Health, Inc. (EVH) Stock Overview | Decifer Markets